Oliaei F, Rasoulinejad A, Seifi B
Department of Internal Medicine, Beheshti Hospital, Babol University, Babol, Iran.
Transplant Proc. 2007 May;39(4):1134-5. doi: 10.1016/j.transproceed.2007.03.032.
Ophthalmological complications in transplanted recipients often due to underlying disorders or drug use consist of anterior segment and posterior segment complications. Among the posterior complications, Central serous chorioretinopathy (CSCR) is related to high-dose steroids, stress, or cyclosporine and usually has a good outcome. The aim of this study was to report a case of CSCR as an ophthalmologic complication of renal transplantation.
A 36-year-old man hospitalized for the treatment of rejection suffered severe visual loss in both eyes. After examination and fluoresein angiography, we diagnosed CSCR due to high-dose steroid therapy for rejection. With tapering of the drug and after about 3 months, visual acuity became normal.
Visual acuity changes must be followed up carefully in all transplant recipients, but CSCR usually has a good prognosis. If it does not improve, retinal laser therapy is needed.
移植受者的眼科并发症通常由基础疾病或药物使用引起,包括前段和后段并发症。在后段并发症中,中心性浆液性脉络膜视网膜病变(CSCR)与高剂量类固醇、压力或环孢素有关,通常预后良好。本研究的目的是报告一例CSCR作为肾移植眼科并发症的病例。
一名因治疗排斥反应住院的36岁男性双眼视力严重下降。经过检查和荧光素血管造影,我们诊断为因高剂量类固醇治疗排斥反应导致的CSCR。随着药物减量,大约3个月后视力恢复正常。
所有移植受者都必须密切随访视力变化,但CSCR通常预后良好。如果没有改善,则需要进行视网膜激光治疗。